These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An interim overview of the safety and tolerability of paroxetine. Dunbar GC Acta Psychiatr Scand Suppl; 1989; 350():135-7. PubMed ID: 2530767 [No Abstract] [Full Text] [Related]
23. [Development of a new gastrointestinal prokinetic; pharmacology of cisapride]. Van Nueten JM; Schuurkes JA J Pharm Belg; 1991; 46(1):17-22. PubMed ID: 2051298 [TBL] [Abstract][Full Text] [Related]
24. Cisapride, a drug for long-term treatment? Harvengt C Acta Gastroenterol Belg; 1990; 53(4):369-71. PubMed ID: 2096582 [No Abstract] [Full Text] [Related]
26. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat. Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256 [TBL] [Abstract][Full Text] [Related]
27. Effect of cisapride on procedure time for small bowel biopsy in children. Wärngård O; Lewander P; Stenhammar L Acta Paediatr; 1994 Oct; 83(10):1114. PubMed ID: 7841720 [No Abstract] [Full Text] [Related]
28. Cisapride to relieve dysphagia. Sharman JM Br J Gen Pract; 1993 Dec; 43(377):534. PubMed ID: 8312027 [No Abstract] [Full Text] [Related]
29. Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo. Crema F; Modini C; Croci T; Langlois M; de Ponti F J Pharmacol Exp Ther; 1999 Mar; 288(3):1045-52. PubMed ID: 10027842 [TBL] [Abstract][Full Text] [Related]
32. [Cisapride for the treatment of irritable stomach--results of 2 multicenter studies]. Rösch W Z Gastroenterol; 1990 Apr; 28 Suppl 1():36-8; discussion 45-7. PubMed ID: 2192505 [No Abstract] [Full Text] [Related]
33. Cisapride marketed for use in gastroesophageal reflux disease. Clin Pharm; 1993 Dec; 12(12):876, 879. PubMed ID: 8137603 [No Abstract] [Full Text] [Related]
34. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases]. Ryss ES; Fishzon-Ryss IuI Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263 [No Abstract] [Full Text] [Related]
35. Cisapride: its use in children. Newell SJ Br J Hosp Med; 1990 Dec; 44(6):408-9. PubMed ID: 2081312 [No Abstract] [Full Text] [Related]
36. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of the effect of serotonin on rat ileal transport by cisapride: evidence in favour of the involvement of 5-HT2 receptors. Moriarty KJ; Higgs NB; Woodford M; Warhurst G; Turnberg LA Gut; 1987 Jul; 28(7):844-8. PubMed ID: 3653752 [TBL] [Abstract][Full Text] [Related]
39. Healing of grade-II and III oesophagitis through motility stimulation with cisapride. Lepoutre L; Van der Spek P; Vanderlinden I; Bollen J; Laukens P Digestion; 1990; 45(2):109-14. PubMed ID: 2190850 [TBL] [Abstract][Full Text] [Related]
40. Dose-finding of cisapride in non-ulcer dyspepsia. Verlinden M Z Gastroenterol; 1990 Apr; 28 Suppl 1():31-5; discussion 72-3. PubMed ID: 2192504 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]